key: cord-1029817-e9g92pjn authors: McFee, R.B. title: SARS2 HUMAN CORONAVIRUS COVID-19 (COVID-19) date: 2020-07-28 journal: Dis Mon DOI: 10.1016/j.disamonth.2020.101063 sha: 18c9cbb4fc799804bc8caeff6fca0a733c0807f1 doc_id: 1029817 cord_uid: e9g92pjn nan From: National Institutes of Health/NIAID In December 2019, a cluster of patients were diagnosed having severe lower respiratory tract febrile illness of unknown origin was reported in Wuhan City, Hubei Province, China. Test results ultimately revealed a novel strain of coronavirus isolated from the bronchoalveolar lavage of the patients, and was determined to be causative for the outbreak [1 -12] . The pulmonary syndrome was very similar to SARS outbreak symptoms, and genetic study of the virus strain revealed an ~80% nucleotide similarity between the human coronavirus SARS (SARS CoV) and this novel strain. The pulmonary syndrome was later named coronavirus disease 2019 (COVID-19) by the World Health Organization. It has also been referred to as SARS CoV2 and SARS 2 CoV. Similar pulmonary syndromes have been recognized as being caused by other strains of the coronavirus family. The most notable examples are the severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS) (11, (13) (14) (15) . The SARS outbreak has been contained, with no known human infection reported since the outbreak of 2003. However there continue to be small outbreaks of MERS reported. Imaging is a critical component of the diagnostic workup, monitoring of disease progression, and follow-up in coronavirus-related pulmonary syndromes [13] [14] [15] . Imaging features in the acute and chronic phases of SARS and MERS as well as COVID-19 share similarities (Table 1) Coronaviruses have been well known since first identified many years ago as primarily zoonotic pathogens, causative of diverse animal illness. However in the 1960's, coronaviruses capable of causing human illness -usually consistent with "the common cold," were identified. In more recent years newly identified human pathogen coronaviruses have caused three significant outbreaks since 2003. The first of these -SARS, emerged in 2003, though largely confined to Hong Kong, and Toronto. The second -MERS a decade later was mostly localized to the Middle East, although cases well beyond that region were diagnosed. The third is COVID-19. In December 2019 several cases of acute respiratory distress syndrome (ARDS) were reported in Wuhan City, China, the result of unknown etiology (2, 3, 5, 6, 9) . Early investigation noted these patients were linked to a local wet market (seafood markets, live animal markets), a common commercial source of food in China. Of concern, animal to human transmission, and ultimately human to human propagation of infections have long been associated with these wet markets over the years, including SARS. During the ensuing investigation numerous samples of patients infected with what was to be designated as SARS2-COVID 19 suggested it came from animals sold in the wet markets (2, 3, 5, 6, 9) . Further research identified the virus as a newly discovered human coronavirus, SARS 2 COVID-19 (COVID-19). Soon after it became clear COVID-19 is transmitted person to person. With a population of eleven million people, Wuhan City became the epicenter for the resulting COVID-19 outbreak, and ultimately starting point for the global pandemic (3, 5-10). Since December 2019, according to World Health Organization (WHO) data, there have been approximately 7 million cases of COVID-19 reported worldwide. This is a dramatic increase in cases since March 2020. The rapidity of COVID-19 spread is significant (3, 16) . Against the backdrop of significant asymptomatic infection, determining the transmissibility factor, also referred to as the basic reproductive number (Ro) for COVID-19 remained a challenge. WHO initial estimates had Ro between 1.4 and 2.5 (17, 18) . Some regions report much higher numbers. Additional research suggests the Ro for COVID -19 is between 1.5 and 6.68, with further calculations estimating Ro of 2.79 and 3.28 17, 19) . The data suggest COVID -19 has a larger Ro than SARS (20) . Regardless of Ro 2 or 3, 4 +/-compared to influenza's lower Ro (<2), let it suffice this is a contagious virus in the context of questionable sustainable immunity and a highly vulnerable population (21) . It should be noted Ro is dependent on several factors -1. different variables utilized; ii) different methods of modeling/calculating; and iii) different estimations (17, 20) . Moreover, R0 is not a static number per se, or necessarily an intrinsic for a pathogen, albeit the general contagiousness of a pathogen based upon host-virus factors contributes to the transmissibility. Three key factors influence Ro: 1. the duration of contagiousness, 2. the likelihood of infection per contact between; 3. contact rate. Viral load, population density, economic, cultural-social and environmental factors also play a role (17) . Regardless of Ro, as of now there are no vaccines against COVID-19, with the issues such as population background immunity, and post infection immune protection currently being studied. Barring more definitive data, it must be assumed most populations are without immunity -herd or otherwise. It appears the average incubation period for COVID-19 is ~ 5 days with a range of 2 -14 days, although much longer periods have been reported in some cases (1, 2, (7) (8) (9) 22) . Coronaviruses are a diverse group of viruses. All are single stranded, zoonotic RNA viruses; they are among the largest known RNA viruses (1, 4, 12, 13, 22, 23) . There are seven known coronaviruses that attack humans -HcoV-OC43, HCoV229E, SARS-COV, HCoV-HKU1, MERS-COV, HCoVNL63, and the most recently identified is SARS 2 COVID-19. In varying degrees of severity, and organ affinity, these seven are capable of causing a wide range of human illness, with symptoms ranging from minimal, as with one of the common cold causing CoV, to severe multisystem organ involvement as seen in COVID-19, including death (1, 4, 12, 13, 22, 23) . SARS, MERS, and COVID-19 are considered highly pathogenic coronaviruses. COVID-19 associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis, and potential therapeutics) COVID-19 coronavirus outbreak. www.worldometers.info/coronavirus The pathogenesis and treatment of the cytokine storm in COVID-19 Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle Clinical features of patients infected with 2019 novel coronavirus in Wuhan Associated with Fatal Coronavirus Disease, United States Emerging Infectious Diseases Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review Radiology Perspective of Coronavirus Disease 2019 (COVID-19): Lessons From Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome The ACE2 Expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS -CoV-2 Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers Middle East respiratory syndrome coronavirus: what does a radiologist need to know? Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease World Health Organization COVID-19 www.who Covid -19 R0: Magic number or conundrum? Infect Dis Rep Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus 2019 The reproductive number of COVID-19 is higher compared to SARS coronavirus Dynamically Modeling SARS and Other Newly Emerging Respiratory Illnesses A novel angiotensin converting enzymerelated carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 SARS-CoV2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor S protein of severe acute respiratory syndrome associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients